129 related articles for article (PubMed ID: 11903375)
41. Distribution of HLA-B alleles in nasopharyngeal carcinoma patients and normal controls in Thailand.
Pimtanothai N; Charoenwongse P; Mutirangura A; Hurley CK
Tissue Antigens; 2002 Mar; 59(3):223-5. PubMed ID: 12074714
[TBL] [Abstract][Full Text] [Related]
42. The relationship between nasopharyngeal carcinoma and the HL-A system among Tunisians.
Betuel H; Camoun M; Colombani J; Day NE; Ellouz R; de-Thé G
Int J Cancer; 1975 Aug; 16(2):249-54. PubMed ID: 1150352
[TBL] [Abstract][Full Text] [Related]
43. [Study on HLA haplotypes in Jiangsu-Zhejiang-Shanghai Han population].
Feng ML; Ji Y; Lu Q; Yang JH; Xie JH; Ji YH; Zhang GL; Yang Y
Yi Chuan Xue Bao; 2003 Jun; 30(6):584-8. PubMed ID: 12939805
[TBL] [Abstract][Full Text] [Related]
44. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma.
Butsch Kovacic M; Martin M; Gao X; Fuksenko T; Chen CJ; Cheng YJ; Chen JY; Apple R; Hildesheim A; Carrington M
Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2673-7. PubMed ID: 16284396
[TBL] [Abstract][Full Text] [Related]
45. Association between microsatellites within the human MHC and nasopharyngeal carcinoma.
Ooi EE; Ren EC; Chan SH
Int J Cancer; 1997 Apr; 74(2):229-32. PubMed ID: 9133461
[TBL] [Abstract][Full Text] [Related]
46. Histocompatibility leukocyte antigen patterns and nasopharyngeal carcinoma.
Simons MJ; Day NE
Natl Cancer Inst Monogr; 1977 Dec; 47():143-6. PubMed ID: 613232
[TBL] [Abstract][Full Text] [Related]
47. The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk.
Hassen E; Nahla G; Bouaouina N; Chouchane L
Mol Biol Rep; 2010 Jan; 37(1):119-26. PubMed ID: 19449168
[TBL] [Abstract][Full Text] [Related]
48. [Apparent correlation between nasopharyngeal carcinoma and HLA phenotype].
Cui HY
Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):249-53. PubMed ID: 7166103
[No Abstract] [Full Text] [Related]
49. HLA-A*26-A*30 and HLA-DRB1*10 could be predictors of nasopharyngeal carcinoma risk in high-risk Tunisian families.
Mokni-Baizig N; Gorgi Y; Elghourabi M; Makhlouf M; Boussen H; Gritli S; Elmay M; Gamoudi A; Elmay A
J Oral Sci; 2017; 59(2):289-296. PubMed ID: 28637989
[TBL] [Abstract][Full Text] [Related]
50. The HLA-DRB1 allele polymorphisms and nasopharyngeal carcinoma.
Yang H; Yu K; Zhang R; Li J; Wei X; Zhang Y; Zhang C; Xiao F; Zhao D; Lin X; Wu H; Yang X
Tumour Biol; 2016 Jun; 37(6):7119-28. PubMed ID: 27059731
[TBL] [Abstract][Full Text] [Related]
51. [HLA typing of nasopharyngeal carcinoma in Hunan province].
Yi YN
Zhonghua Zhong Liu Za Zhi; 1988 Jul; 10(4):267-9. PubMed ID: 3266851
[TBL] [Abstract][Full Text] [Related]
52. HLA and nasopharyngeal carcinoma in North American Caucasoids.
Moore SB; Pearson GR; Neel HB; Weiland LH
Tissue Antigens; 1983 Jul; 22(1):72-5. PubMed ID: 6577695
[TBL] [Abstract][Full Text] [Related]
53. Immunogenetic aspects of nasopharyngeal carcinoma (NPC) III. HL-a type as a genetic marker of NPC predisposition to test the hypothesis that Epstein-Barr virus is an etiological factor in NPC.
Simons MJ; Wee GB; Chan SH; Shanmugaratnam K; Day NE; de-Thé G
IARC Sci Publ (1971); 1975; (11 Pt 2):249-58. PubMed ID: 191368
[TBL] [Abstract][Full Text] [Related]
54. HLA gene frequencies of northern Thais.
Fongsatikul L; Nantachit N; Kamtorn N; Leetrakool N
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S38-42. PubMed ID: 9347644
[TBL] [Abstract][Full Text] [Related]
55. Argonaute 2 and nasopharyngeal carcinoma: a genetic association study and functional analysis.
Li P; Meng J; Zhai Y; Zhang H; Yu L; Wang Z; Zhang X; Cao P; Chen X; Han Y; Zhang Y; Chen H; Ling Y; Li Y; Cui Y; Bei JX; Zeng YX; He F; Zhou G
BMC Cancer; 2015 Nov; 15():862. PubMed ID: 26545861
[TBL] [Abstract][Full Text] [Related]
56. HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinoma.
Herait P; Tursz T; Guillard MY; Hanna K; Lipinski M; Micheau C; Sancho-Garnier H; Schwaab G; Cachin Y; Degos L
Tissue Antigens; 1983 Nov; 22(5):335-41. PubMed ID: 6419386
[TBL] [Abstract][Full Text] [Related]
57. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping.
Lu CC; Chen JC; Tsai ST; Jin YT; Tsai JC; Chan SH; Su IJ
Int J Cancer; 2005 Jul; 115(5):742-6. PubMed ID: 15729690
[TBL] [Abstract][Full Text] [Related]
58. Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan.
Lin HJ; Cherng JM; Hung MS; Sayion Y; Lin JC
J Biomed Sci; 2005 Dec; 12(6):925-36. PubMed ID: 16307312
[TBL] [Abstract][Full Text] [Related]
59. Genetic susceptibility to the endemic form of NPC.
Bei JX; Zuo XY; Liu WS; Guo YM; Zeng YX
Chin Clin Oncol; 2016 Apr; 5(2):15. PubMed ID: 27121875
[TBL] [Abstract][Full Text] [Related]
60. Human leukocyte antigens -A, -B, -C, and -DR and nasopharyngeal carcinoma in northern China.
Zhu XN; Chen R; Kong FH; Liu W
Ann Otol Rhinol Laryngol; 1990 Apr; 99(4 Pt 1):286-7. PubMed ID: 2327697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
